XML 40 R23.htm IDEA: XBRL DOCUMENT v3.19.1
RESEARCH AND DEVELOPMENT ACTIVITY (Details) - INKmune License Agreement - Patent rights - Immune Ventures, LLC ("Immune Ventures")
12 Months Ended
Dec. 31, 2018
USD ($)
Each Phase I initiation  
Research and Development Arrangement, Contract to Perform for Others [Line Items]  
Payment method of milestone payments $ 25,000
Each Phase II initiation  
Research and Development Arrangement, Contract to Perform for Others [Line Items]  
Payment method of milestone payments 250,000
Each Phase III initiation  
Research and Development Arrangement, Contract to Perform for Others [Line Items]  
Payment method of milestone payments 350,000
Each NDA/EMA filing  
Research and Development Arrangement, Contract to Perform for Others [Line Items]  
Payment method of milestone payments 1,000,000
Each NDA/EMA awarded  
Research and Development Arrangement, Contract to Perform for Others [Line Items]  
Payment method of milestone payments $ 9,000,000